The intrinsic enzymatic activity of procarboxypeptidase U (TAFI) does not significantly influence the fibrinolysis rate: a rebuttal
Open Access
- 22 March 2007
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 5 (6) , 1334-1336
- https://doi.org/10.1111/j.1538-7836.2007.02539.x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Thrombin-activable Fibrinolysis Inhibitor (TAFI) Zymogen Is an Active CarboxypeptidasePublished by Elsevier ,2007
- The intrinsic enzymatic activity of plasma procarboxypeptidase U (TAFI) can interfere with plasma carboxypeptidase N assaysAnalytical Biochemistry, 2006
- The Intrinsic Threshold of the Fibrinolytic System Is Modulated by Basic Carboxypeptidases, but the Magnitude of the Antifibrinolytic Effect of Activated Thrombin-activable Fibrinolysis Inhibitor Is Masked by Its InstabilityJournal of Biological Chemistry, 2004
- Carboxypeptidase U (TAFIa) prevents lysis from proceeding into the propagation phase through a threshold‐dependent mechanismJournal of Thrombosis and Haemostasis, 2004
- Proteolytic activation of purified human procarboxypeptidase UClinica Chimica Acta; International Journal of Clinical Chemistry, 2000
- A Study of the Mechanism of Inhibition of Fibrinolysis by Activated Thrombin-activable Fibrinolysis InhibitorJournal of Biological Chemistry, 1998
- TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin ComplexPublished by Elsevier ,1996